Fennec Pharmaceuticals Inc

FENCNASDAQ · USD
10.62USD0.00 (+1.05%)
339

Fennec Pharmaceuticals Inc (FENC) Covered Calls

As of September 23, 2026, FENC has 5 covered call opportunities in the coming three months. Return ranges from 17.3 to 84.2% until expiration. Annualized return ranges from 30.3 to 127.0%. The nearest expiration is February 19, 2027. Maximum potential profit is $919.

Read more

Running FENC covered calls helps you generate consistent income from Fennec Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Fennec Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best FENC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if FENC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling FENC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Fennec Pharmaceuticals Inc covered call is worth writing.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Income-focused investors, long-term FENC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling FENC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Fennec Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile49.60% Neutral
  • Market cap (M$)372
  • 52 weeks high-19.85%
  • 52 weeks low87.96%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$17.67
    66.38% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-12
  • P/E—
  • Future P/E11.28
  • EPS (ttm)-0.13
  • EPS growth next 5 years—

As of September 23, 2026

2027-05-2124220.0083.320.105.00919.0084.23127.05-0.92+0.4804.90
2027-05-2124217.5060.400.155.00674.0061.7893.18-1.37+0.5104.85
2027-05-2124215.0037.490.305.00439.0040.2460.69-2.75+0.5404.70
2027-02-1915112.5014.570.305.00189.0017.3241.87-2.75+0.5824.70
2027-05-2124212.5014.570.605.00219.0020.0730.28-5.50+0.5904.40

As of September 23, 2026

Sell covered calls with the data behind you

Find the best FENC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial